Cisatracurium Besylate Injection 20mg/10ml Cisatra

Trade Name:Cisatra

Manufacturer:Themis Medicare Ltd

Presentation: Injection

Strength: 20mg/10ml

What is the purpose of Cisatracurium Besylate Inj?

Descriptions: Cisatracurium Besylate Inj is used both before and during operation to relax muscles and make intubation easier. This drug should only be administered by your doctor or a person working closely with them.

Is citatracurium a drug that increases alertness?

High Alert Drugs: When this medication is administered incorrectly, there is a higher risk that it will seriously injure the patient. Ther.

What class of medication is ciatracurium?

A non-depolarizing, intermediate-acting neuromuscular blocking medication is cisatracurium besylate (NMBD). The structure of the 1R cis-1-prime R cis isomer of astacurium, cisatracurium, is benzylisoquinolinium.

What adverse reactions may Cisatracurium Besylate Inj 20mg/10ml cause?

  • Cisatracurium’s typical adverse effects could include:
  • a slow heartbeat
  • vertigo; or
  • flushing (warmth, redness, or tingly feeling).

To know more Click here

How long till Cisatracurium Besylate Inj stops working?

Guidelines for administering Cisatracurium injection (5 mg/ml) are shown in Table 6. In patients receiving long-term (up to 6 days) infusions of cisatracurium in the intensive care unit, the median time to complete spontaneous recovery was roughly 50 minutes.

When should Cisatracurium Besylate Inj be used?

Cisatracurium can be administered as a sedative or adjuvant to general anaesthesia in the intensive care unit (ICU) to relax skeletal muscles and facilitate tracheal intubation and mechanical breathing.

Is tachycardia possible with Cisatracurium Besylate Inj?

Three of the 21 patients who received 3xED95 cisatracurium showed haemodynamic changes greater than 20% (2 showed hypotension and 1 tachycardia), while two of the 21 patients who received high-dose cisatracurium showed a tachycardia that was predetermined to be statistically but not clinically significant.

In renal failure, is Cisatracurium Besylate Inj safe?

Conclusions: According to the findings of this clinical investigation, cisatracurium is a good option for individuals with renal failure. The considerable variation in the recovery parameters in patients with renal failure is indicative of the requirement for an intraoperative neuromuscular surveillance.

Dosatracurium: Does it result in malignant hyperthermia?

Existing research on muscle relaxants suggests that succinylcholine, a depolarizing neuromuscular blocker, is mostly responsible for MH; nevertheless, there have been a few isolated instances of MH being caused by nondepolarizing NM blockers. Cisatracurium-induced MH has only ever been documented once before.

How long may Cisatracurium Besylate Inj be kept at room temperature?

In summary, this research proved that cisatracurium’s onset time was unaffected by storage at ambient temperature. It offers justification for keeping cisatracurium at room temperature for a maximum of 21 days.

What distinguishes atracurium from cisatracurium?

Atracurium is a more potent neuromuscular blocking agent than cisatracurium at the same dose (2 ED95), while cisatracurium at higher doses (4 ED95 and 6 ED95) offers more potent, quicker neuromuscular blocking with longer duration of action, stable hemodynamic status, and no histamine-related side effects.

We are a regular distributor, a supplier based in India, and an exporter with operations in more than five foreign countries, including the Oman, Qatar, Soudi Arabia, Egypt, UAE, etc. In the unlikely occasion if you’re looking for a product or brand, Click here.